Key result
Pharmacological silencing or surgical removal of the carotid body presents a potential therapeutic target for reestablishing neural control of cardiorespiratory balance in chronic heart failure.
Why the study?
The role of the carotid body in chronic heart failure and its potential as a treatment target to restore cardiorespiratory balance requires clarification based on its chemosensing and neural output mechanisms.
Should not yet alter HF management; hypothesis-generating for carotid body modulation trials in patients.
Significant insight into the mechanisms involved in chronic heart failure (CHF) have been provided by Schultz and his associates at the University of Nebraska Medical Center with the use of pacing-induced heart failure rabbits. Critical among the CHF mechanisms was the role of the carotid body (CB). The stimulated CB produces a wide array of systemic reflex responses; certainly those in the cardiopulmonary (CP) system are the most important in CHF. This generates a question as to whether the CB could serve as a target for some kind of treatment to reestablish control of cardiorespiratory balance in CHF. Any treatment would have to be based on a solid understanding of the mechanisms of chemosensing by the CB as well as the transducing of that sensing into neural activity sent to the medullary centers and regions of autonomic outflow to the periphery. Two avenues of treatment could be to (1) silence or attenuate the CB's neural output pharmacologically and (2) excise the CBS. There is a long history of CB removal mostly as a remedy for chronic obstructive lung disease. Results have been inconclusive as to the effectiveness of this procedure. But if carefully planned, the procedure might be a helpful treatment.
No takes yet. Share an insight, caveat, or question.
Robert Schaefer Fitzgerald (2014) conducted a review in Chronic heart failure, COPD, asthma. Carotid body modulation or removal (glomectomy) was evaluated. Pharmacological silencing or surgical removal of the carotid body presents a potential therapeutic target for reestablishing neural control of cardiorespiratory balance in chronic heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: